Skip to main content

Table 3 Immunohistochemical expression of cyclin E2 and Ki67 in CD3-positive tumor population of TNKLPD

From: Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts

Case No. Diagnosis Ohshima category Histology Cyclin E2 (%) Ki67 (%) Follow up OS (mth)
1 CAEBV A1 P 3 5 Alive 55
2 CAEBV A1 P 8 NA Dead (AHCT complications) 48
3 CAEBV A1 P 0 0 Alive 6
4 STLPDC A2 P 8 6 Alive 64
5 STLPDC A2 P 1 1 Alive cgraft rejection) 95
6 STLPDC A2 P 5 12 Alive 31
7 STLPDC A2 P 8 3 Dead 14
8 CAEBV vs STLPDC A1 or A2 P 8 1 Alive 94.4
9 CAEBV vs STLPDC A1 or A2 P 7 8 Alive 9.2
10 CAEBV vs STLPDC A1 or A2 P 8 9 Alive 32.5
11 CAEBV vs STLPDC A1 or A2 P 44 4 Dead 21.8
12 STLPDC A3 M 90 NA Dead 0.4
13 STLPDC A3 M 70 75 Alive 21
14 STLPDC B M 49 44 Dead 0.83
15 STLPDC B M 35 NA Dead 2
16 STLPDC B M 70 70 Dead 1
17 STLPDC B M 15 60 Dead 1.16
18 STLPDC B M 30 82 NA NA
19 STLPDC B M 35 90 Dead 1
20 STLPDC B M 18 23 Dead 0.1
21 STLPDC B M 65 52 Dead 2.2
22 favour STLPDC A3 or B M NA NA Dead 0.7
  1. Abbreviations: NA not available, mth months, P polymorphic, M monomorphic.